Ledger.Open graph →
SEC Form D · filed June 14, 2016

Aclaris Therapeutics, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MALVERN, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Neal Walker · Phoenixville, PAExec · DirectorStuart Shanler · MALVERN, PAExecAnand A. Mehra · Malvern, PADirectorAlbert A. Cha · Malvern, PADirectorKamil Ali-Jackson · MALVERN, PAExecChristopher A. Molineaux · Malvern, PADirectorFrank Ruffo · MALVERN, PAExecChristopher Powala · Wayne, PAExecRichard A. Bierly · MALVERN, PADirectorSteven A. Tullman · MALVERN, PADirectorSteven A. Tullman · MALVERN, PADirectorChristopher Powala · MALVERN, PAExecNeal Walker · Wayne, PAExec · DirectorRichard A. Bierly · MALVERN, PADirectorStuart Shanler · MALVERN, PAExecAnand A. Mehra · Malvern, PADirectorAlbert A. Cha · Malvern, PADirectorKamil Ali-Jackson · Malvern, PAExecChristopher A. Molineaux · Malvern, PADirectorFrank Ruffo · MALVERN, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗